{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,30]],"date-time":"2026-03-30T18:52:45Z","timestamp":1774896765870,"version":"3.50.1"},"reference-count":29,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2018,2,1]],"date-time":"2018-02-01T00:00:00Z","timestamp":1517443200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,2,1]],"date-time":"2018-02-01T00:00:00Z","timestamp":1517443200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2018,1,7]],"date-time":"2018-01-07T00:00:00Z","timestamp":1515283200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2018,2]]},"DOI":"10.1016\/j.vaccine.2017.12.076","type":"journal-article","created":{"date-parts":[[2018,1,8]],"date-time":"2018-01-08T18:52:42Z","timestamp":1515437562000},"page":"811-817","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":25,"title":["An assessment of shedding with the oral rabies virus vaccine strain SPBN GASGAS in target and non-target species"],"prefix":"10.1016","volume":"36","author":[{"given":"Ad","family":"Vos","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Conrad","family":"Freuling","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Steffen","family":"Ortmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antje","family":"Kretzschmar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dietmar","family":"Mayer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Annette","family":"Schliephake","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas","family":"M\u00fcller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2017.12.076_b0005","first-page":"173","article-title":"Oral vaccination of wildlife against rabies: opportunities and challenges in prevention and control","volume":"119","author":"Rupprecht","year":"2004","journal-title":"Dev Biol (Basel)"},{"issue":"1","key":"10.1016\/j.vaccine.2017.12.076_b0010","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.tvjl.2014.10.026","article-title":"Terrestrial rabies control in the European Union: historical achievements and challenges ahead","volume":"203","author":"M\u00fcller","year":"2015","journal-title":"Vet J"},{"key":"10.1016\/j.vaccine.2017.12.076_b0015","doi-asserted-by":"crossref","first-page":"e0003953","DOI":"10.1371\/journal.pntd.0003953","article-title":"Spatio-temporal use of oral rabies vaccinesin fox rabies elimination programmes in Europe","volume":"9","author":"M\u00fcller","year":"2015","journal-title":"PLoS Negl Trop Dis"},{"issue":"32","key":"10.1016\/j.vaccine.2017.12.076_b0020","doi-asserted-by":"crossref","first-page":"3938","DOI":"10.1016\/j.vaccine.2017.06.022","article-title":"Oral vaccination of wildlife against rabies: differences among host species in vaccine uptake efficiency","volume":"35","author":"Vos","year":"2017","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2017.12.076_b0025","unstructured":"Council of Europe. Evaluation of safety of veterinary vaccines and immunosera \u2013 \u00a75.2.6. In: European Pharmacopoeia 7.7; Strasbourg, EDQM; 2013. p. 5275\u20137."},{"key":"10.1016\/j.vaccine.2017.12.076_b0030","unstructured":"WHO. WHO expert consultation on rabies, second report. WHO Technical report series 982. Geneva: World Health Organization; 2013."},{"key":"10.1016\/j.vaccine.2017.12.076_b0035","doi-asserted-by":"crossref","first-page":"20120140","DOI":"10.1098\/rstb.2012.0140","article-title":"The final stages of the global eradication of poliomyelitis","volume":"368","author":"Grassly","year":"2013","journal-title":"Phil Trans Roy Soc B"},{"issue":"2","key":"10.1016\/j.vaccine.2017.12.076_b0040","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1086\/315246","article-title":"Comparison of the safety, vaccine virus shedding and immunogenicity of influenza virus vaccine, trivalent, types A and B, live cold-adapted, administered to human immunodeficiency virus (HIV)-infected and non-HIV infected adults","volume":"181","author":"King","year":"2000","journal-title":"J Infect Dis"},{"issue":"26","key":"10.1016\/j.vaccine.2017.12.076_b0045","doi-asserted-by":"crossref","first-page":"4322","DOI":"10.1016\/j.vaccine.2011.04.022","article-title":"Shedding of Ann Arbor strain live attenuated influenza vaccine virus in children 6\u20139 months of age","volume":"29","author":"Mallory","year":"2011","journal-title":"Vaccine"},{"issue":"10","key":"10.1016\/j.vaccine.2017.12.076_b0050","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1016\/S1473-3099(08)70231-7","article-title":"Rotavirus vaccines: viral shedding and risk of transmission","volume":"8","author":"Anderson","year":"2008","journal-title":"Lancet Infect Dis"},{"issue":"51","key":"10.1016\/j.vaccine.2017.12.076_b0055","doi-asserted-by":"crossref","first-page":"7194","DOI":"10.1016\/j.vaccine.2009.09.030","article-title":"Oral immunization of raccoons and skunks with a canine adenovirus recombinant rabies vaccine","volume":"27","author":"Henderson","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2017.12.076_b0060","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1056\/NEJMoa010560","article-title":"Human infection due to recombinant vaccinia-rabies glycoprotein virus","volume":"345","author":"Rupprecht","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2017.12.076_b0065","unstructured":"CDC. Human vaccinia infection after contact with a raccoon rabies vaccine bait \u2013 Pennsylvania, 2009. MMWR Morb Mortal Wkly Rep 2009:58(43):1204\u20137."},{"key":"10.1016\/j.vaccine.2017.12.076_b0070","doi-asserted-by":"crossref","first-page":"14141","DOI":"10.1128\/JVI.79.22.14141-14148.2005","article-title":"A single amino acid change in rabies virus glycoprotein increases virus spread and enhances virus pathogenicity","volume":"79","author":"Faber","year":"2005","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2017.12.076_b0075","doi-asserted-by":"crossref","first-page":"3374","DOI":"10.1128\/JVI.76.7.3374-3381.2002","article-title":"Overexpression of the rabies virus glycoprotein results in enhancement of apoptosis and antiviral immune response","volume":"76","author":"Faber","year":"2002","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2017.12.076_b0080","doi-asserted-by":"crossref","first-page":"7041","DOI":"10.1128\/JVI.00357-07","article-title":"Dominance of a nonpathogenic glycoprotein gene over a pathogenic glycoprotein gene in rabies virus","volume":"81","author":"Faber","year":"2007","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2017.12.076_b0085","series-title":"Current laboratory techniques in rabies diagnosis, research and prevention","first-page":"237","article-title":"Attenuated vaccines for veterinary use","author":"Vos","year":"2015"},{"issue":"11","key":"10.1016\/j.vaccine.2017.12.076_b0090","doi-asserted-by":"crossref","first-page":"3970","DOI":"10.1128\/JCM.00612-10","article-title":"Improved safety for molecular diagnosis of classical rabies viruses by use of a taqman real-time reverse transcription-PCR \u201cdouble check\u201d strategy","volume":"48","author":"Hoffmann","year":"2010","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.vaccine.2017.12.076_b0095","series-title":"Laboratory techniques in rabies","first-page":"96","article-title":"Virus isolation in neuroblastoma cell culture","author":"Webster","year":"1996"},{"key":"10.1016\/j.vaccine.2017.12.076_b0100","series-title":"Wildlife rabies control","first-page":"119","article-title":"Safety aspects of recombinant rabies vaccines","author":"Rupprecht","year":"1992"},{"issue":"1","key":"10.1016\/j.vaccine.2017.12.076_b0105","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1017\/S0950268899002666","article-title":"An update on safety studies of SAD B19 rabies virus vaccine in target and non-target species","volume":"123","author":"Vos","year":"1999","journal-title":"Epidemiol Infect"},{"key":"10.1016\/j.vaccine.2017.12.076_b0110","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1099\/0022-1317-71-1-37","article-title":"Primary multiplication site of the vaccinia-rabies glycoprotein recombinant virus administered to foxes by the oral route","volume":"71","author":"Thomas","year":"1990","journal-title":"J Gen Virol"},{"key":"10.1016\/j.vaccine.2017.12.076_b0115","unstructured":"WHO. Oral immunization of dogs against rabies: report of the sixth WHO consultation. Geneva: World Health Organization; 1998 [WHO\/EMC\/ZDI\/98.13]."},{"issue":"31","key":"10.1016\/j.vaccine.2017.12.076_b0120","doi-asserted-by":"crossref","first-page":"4511","DOI":"10.1016\/S0264-410X(01)00186-4","article-title":"Rapid clearance of SAG-2 rabies virus from dogs after oral vaccination","volume":"19","author":"Orciari","year":"2001","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2017.12.076_b0125","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1007\/BF01317147","article-title":"Oral rabies vaccination of skunks and foxes with a recombinant human adenovirus vaccine","volume":"123","author":"Charlton","year":"1992","journal-title":"Arch Virol"},{"key":"10.1016\/j.vaccine.2017.12.076_b0130","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1006\/biol.1995.0045","article-title":"Characterization of a human adenovirus 5: rabies glycoprotein recombinant vaccine reisolated from orally vaccinated skunks","volume":"23","author":"Lutze-Wallace","year":"1995","journal-title":"Biologicals"},{"issue":"47","key":"10.1016\/j.vaccine.2017.12.076_b0135","doi-asserted-by":"crossref","first-page":"6619","DOI":"10.1016\/j.vaccine.2009.08.005","article-title":"Safety studies on an adenovirus recombinant vaccine for rabies (AdRG1.3-ONRAB) in target and non-target species","volume":"27","author":"Knowles","year":"2009","journal-title":"Vaccine"},{"issue":"17","key":"10.1016\/j.vaccine.2017.12.076_b0140","doi-asserted-by":"crossref","first-page":"2207","DOI":"10.1016\/j.vaccine.2013.02.057","article-title":"An assessment of ONRAB oral rabies vaccine persistence in free-ranging mammal populations in Ontario, Canada","volume":"31","author":"Sobey","year":"2013","journal-title":"Vaccine"},{"issue":"2","key":"10.1016\/j.vaccine.2017.12.076_b0145","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1111\/tbed.12381","article-title":"Survival of African swine fever virus in excretions from pigs experimentally infected with the Georgia 2007\/1 isolate","volume":"64","author":"Davies","year":"2017","journal-title":"Transbound Emerg Dis"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X1731839X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X1731839X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T10:24:01Z","timestamp":1759400641000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X1731839X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,2]]},"references-count":29,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2018,2]]}},"alternative-id":["S0264410X1731839X"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2017.12.076","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2018,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"An assessment of shedding with the oral rabies virus vaccine strain SPBN GASGAS in target and non-target species","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2017.12.076","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}